Percutaneous Neuromuscular Electrical Stimulation in Patients With Chronic Low Back Pain
PNMESlowback
Effectiveness of Percutaneous Neuromuscular Electrical Stimulation on Lumbar Multifidus in Combination With a Protocol of Motor Control Exercises in Patients With Chronic Low Back Pain
1 other identifier
interventional
64
1 country
1
Brief Summary
Chronic low back pain is a common musculoskeletal condition affects the general population. Low back pain constitutes a major burden to health care system and society. Several authors have found that the deep abdominal muscles and multifidus are affected in low back pain. Dry needling has shown improve the cross-sectional area of the multifidus. Percutaneous electrical nerve stimulation has shown reduce pain in several conditions. There are not studies that had investigated the impact of percutaneous neuromuscular electrical stimulation (PNMES) in the deep muscles in patients with chronic low back pain. Hypothesis: PNMES in the multifidus muscle plus motor control exercise program in patients with chronic low back pain is better than sham PNMES plus exercise and transcutaneous electrical nerve stimulation (TENS) plus exercise
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable low-back-pain
Started Apr 2021
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2020
CompletedFirst Posted
Study publicly available on registry
January 28, 2020
CompletedStudy Start
First participant enrolled
April 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2024
CompletedMay 15, 2023
May 1, 2023
3.2 years
January 15, 2020
May 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Increased cross-sectional area in activation
The increase in height from the resting position to the submaximal contraction in the lumbar multifidus will be measured
Baseline, one hour from baseline after PNMES treatment 1, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Changes in the measurements of the multifidus and tranverse of the abdomen at rest.
Changes in the height of the multifidus at rest
Baseline, one hour from baseline after PNMES treatment 1, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Secondary Outcomes (14)
Intensity of Pain
(Baseline, one hour from baseline after PNMES treatment 1 (only at rest), 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Pressure pain threshold using an algometer
Baseline, one hour from baseline after PNMES treatment 1, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Temporal summation
Baseline, one hour from baseline after PNMES treatment 1, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Conditioned pain modulation
Baseline, one hour from baseline after PNMES treatment 1, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
Pain Grade Questionnaire
Baseline, 6 weeks from baseline, 18 weeks from baseline and 30 weeks from baseline
- +9 more secondary outcomes
Study Arms (4)
PNMES plus exercise
EXPERIMENTAL6-week intervention program with 3 treatment sessions of PNMES and motor control exercise program.
Sham PNMES (introducing the needle) plus exercise
SHAM COMPARATORSham PNMES (introducing the needle) plus motor control exercise program
TENS plus exercise
ACTIVE COMPARATOR6-week intervention program with 3 treatment sessions of TENS plus motor control exercise program.
Placebo PNMES (without inserting the needle) plus exercise
PLACEBO COMPARATOR6-week intervention program with 3 treatment sessions of placebo PNMES (without inserting the needle) and exercise
Interventions
The technique consists of a muscular stimulation of the deep lumbar multifidus by means of a TENS current applied through four dry needling or acupuncture needles introduced by ultrasound guidance in said muscle 30 minutes. This will add to a protocol of motor control exercises for deep abdominal and lumbar muscles.
The same procedure will be performed as in the experimental treatment, but in this case, the electric current will be placebo and only the first 15 seconds will slightly notice it. This will add to a protocol of motor control exercises for deep abdominal and lumbar muscles.
Transcutaneous electrical nerve stimulation will be applied through 4 patches / adhesives placed in your lower back for 30 minutes. This will add to a protocol of motor control exercises for deep abdominal and lumbar muscles.
The same procedure will be performed as in the experimental treatment, but in this case, the needle will not be inserted and the electric current will be placebo and only the first 15 seconds will slightly notice it. This will add to a protocol of motor control exercises for deep abdominal and lumbar muscles.
Eligibility Criteria
You may qualify if:
- \- Low back pain more than 90 days of evolution
You may not qualify if:
- Spondylarthrosis
- History of fractures, luxations, surgery and/or musculoskeletal disorders in low back and lower limb.
- Leg pain or neuropathic pain (LANSS \<12).
- Neurological disorders, inflammatory and/or degenerative diseases.
- Having received as treatment techniques that involve needles on the previous 6 months to study enrollment or having received percutaneous electrical stimulation as a treatment before.
- Physiotherapy treatment in the last 4 weeks.
- Specific lumbar pathology, fibromyalgia, unstable cardiovascular diseases, pregnant women or under suspect of pregnancy.
- Contraindications of needle's insertions: anticoagulant therapy, needle phobia, diabetes, hypothyroidism, lymphoedema, muscular diseases).
- Contraindications of electrical current.
- Drugs: morphine or opioids drugs.
- Depression
- Judicial dispute
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Rey Juan Carlos
Alcorcón, Madrid, 28922, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josue Fernández-Carnero, PhD
Universidad Rey Juan Carlos
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 15, 2020
First Posted
January 28, 2020
Study Start
April 10, 2021
Primary Completion
June 10, 2024
Study Completion
December 10, 2024
Last Updated
May 15, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share